Nordic region

Focus on companies in Scandinavia, but with a global reach in terms of operation and exit possibilites

Expansion stage

Late product development phase, launch phase or product line extension

Medtech

A quantum leap in improvement
Consumable focused business model

Biotech tools

Own technology platform

Instruments
Test panels

Initial deal size

SEK 30-100 M, with a follow-on reserve of 150% of initial investment

Ownership

Lead investor (>50%) with very strong decision power

Exit

New investments are made with the intent to be long term holdings adding cash flow and value to SLS portfolio